Access-Power & Co., Inc. (ACCR) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 3.05: the stock has moved about 205% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerAccess-Power & Co., Inc. (ACCR) trades at $0.00144. Access-Power & Co., Inc. operates in the medical marijuana clone sector, manufacturing and distributing products under the Clones By Drones and Clones by Cars brands. Sector: Communication services.
Price as of Sep 10, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for ACCR: ACCR does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ACCR against Communication Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
These figures come from statements filed 12 months ago — the most recent this company has published.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
ACCR: 1/2 scored disciplines lean bearish. Dominant signal: Izzy Englander bearish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Access-Power & Co., Inc. (ACCR) Media & Communications Profile
Access-Power & Co., Inc. focuses on manufacturing and distributing medical marijuana clones and related products. Operating under brands like Clones By Drones and Clones by Cars, the company also ventures into pet calming products. Its small size and OTC market presence differentiate it within the telecommunications services sector.
What Is the Investment Thesis for ACCR?
Investing in Access-Power & Co., Inc. presents a high-risk, high-reward scenario given its presence in the volatile OTC market and the evolving cannabis industry. The company's negative P/E ratio of -3.08 and a negative profit margin of -14.1% indicate financial challenges. However, a gross margin of 59.0% suggests potential profitability if operational efficiencies improve. Growth catalysts include expansion of its Clones By Drones and Clones by Cars brands and increased adoption of its pet calming products. The company's beta of 3.05 indicates high volatility, reflecting the speculative nature of the stock.
Based on FMP financials and quantitative analysis
ACCR Key Highlights
Market capitalization of $0.00B indicates a micro-cap company with limited financial resources.
- P/E ratio of -3.08 reflects current unprofitability, requiring careful monitoring of future earnings potential.
- Gross margin of 59.0% suggests a strong potential for profitability if sales volume increases and operational costs are managed effectively.
- Beta of 3.05 indicates high volatility compared to the market, making it a higher-risk investment.
- The company operates with only 1 employee, highlighting its small scale and potential operational constraints.
Who Are ACCR's Competitors?
ACCR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| NUVR Nuvera Communications, Inc. | $16.75 | -1.76% | $87.6M | 519-signal |
| RDCM RADCOM Ltd. | $9.96 | -0.99% | $167M | 495-pillar |
| CXDO Crexendo, Inc. | $5.71 | -1.55% | $185M | 605-pillar |
| GLTK GlobalTech Corporation | $4.50 | 0.00% | $227M | 529-signal |
| LICT LICT Corporation | $11850.00 | +0.42% | $227M | 529-signal |
| ATNI ATN International, Inc. | $30.65 | +2.44% | $471M | 905-pillar |
| LMGHF LINK Mobility Group Holding ASA | $2.10 | 0.00% | $593M | 509-signal |
| OOMA Ooma, Inc. | $22.67 | -0.74% | $623M | 845-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are ACCR's Key Strengths?
Niche market focus on medical marijuana clones.
- Established brand names (Clones By Drones, Clones By Cars).
- Online platform for pet calming products (mycbdpets.com).
What Are ACCR's Weaknesses?
Small scale of operations (1 employee).
- Limited financial resources (market cap of $0.00B).
- Negative profitability (negative P/E and profit margin).
What Could Drive ACCR Stock Higher?
ACCR catalyst: Expansion of the Clones By Drones and Clones by Cars brands through increased distribution and marketing efforts.
- Growing demand for calming pet products, driving increased sales through the mycbdpets.com platform.
- Potential regulatory changes in the cannabis industry that could create new market opportunities.
- Strategic partnerships with established cannabis companies to expand market reach and access new technologies.
- Development of new cannabis-based products to diversify the company's product line.
What Are the Key Risks for ACCR?
Financial-distress signal — its Altman Z-Score of -3.06 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-19.6%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Regulatory changes in the cannabis industry that could restrict or prohibit the company's operations.
- Intense competition from larger cannabis companies with greater financial resources.
- Fluctuations in the price of cannabis, impacting the company's profitability.
- Limited financial resources and small scale of operations, hindering the company's ability to compete effectively.
- Low liquidity and trading volume of the stock, making it difficult to exit positions.
What Are the Growth Opportunities for ACCR?
- Expansion of Clones By Drones and Clones by Cars: The company can increase its market share by expanding the distribution network for its marijuana clone products. This involves targeting new geographic markets and establishing partnerships with dispensaries and growers. The legal cannabis market is projected to reach $42.9 billion by 2027, providing a substantial growth opportunity for clone providers. Timeline: Ongoing.
- Increased Adoption of Calming Pet Products: The market for pet calming products is growing as pet owners seek natural remedies for anxiety and stress in animals. Access-Power & Co., Inc. can capitalize on this trend by expanding its mycbdpets.com platform and introducing new product offerings. The pet CBD market is expected to reach $2.5 billion by 2028. Timeline: Ongoing.
- Strategic Partnerships: Forming strategic alliances with established players in the cannabis industry can provide Access-Power & Co., Inc. with access to new markets, technologies, and resources. This includes partnerships with cultivation facilities, research institutions, and distribution networks. Timeline: 12-24 months.
- Product Diversification: Expanding the product line beyond clones and calming pet products can reduce the company's reliance on specific market segments. This includes developing new cannabis-based products, such as edibles, topicals, and concentrates. Timeline: 18-36 months.
- Online Marketing and E-commerce: Investing in online marketing and e-commerce capabilities can enhance the company's brand visibility and reach a wider customer base. This includes optimizing the mycbdpets.com platform for online sales and implementing targeted advertising campaigns. The e-commerce cannabis market is projected to grow significantly in the coming years. Timeline: Ongoing.
What Are ACCR's Competitive Advantages?
- Brand recognition within the niche market of marijuana clones.
- Proprietary cultivation techniques for producing high-quality clones.
- Established online platform for selling calming pet products.
What Does ACCR Do?
Founded in 1996, Access-Power & Co., Inc. is a Michigan-based company specializing in the medical marijuana clone market. The company manufactures and distributes medical marijuana clones under the brand names Clones By Drones and Clones by Cars. These products are targeted towards medical marijuana growers and dispensaries. In addition to its core marijuana clone business, Access-Power & Co., Inc. also offers calming pet products through its online platform, mycbdpets.com, diversifying its product line within the broader wellness market. The company operates with a small team, reflecting its early-stage nature and focus on niche markets within the cannabis industry.
What Products and Services Does ACCR Offer?
- Manufactures medical marijuana clones.
- Distributes clones under the Clones By Drones brand.
- Distributes clones under the Clones By Cars brand.
- Offers calming pet products through mycbdpets.com.
- Operates in the cannabis industry.
- Focuses on niche markets within the cannabis sector.
How Does ACCR Make Money?
- Manufacturing and selling medical marijuana clones to growers and dispensaries.
- Selling calming pet products directly to consumers through an online platform.
- Generating revenue through product sales.
What Industry Does ACCR Operate In?
Access-Power & Co., Inc. operates within the evolving telecommunications services sector, specifically focusing on the niche market of medical marijuana clones and related products. The cannabis industry is characterized by rapid growth, regulatory changes, and increasing competition. While the telecommunications sector is broad, Access-Power's focus on specialized products differentiates it. The company's success depends on navigating regulatory hurdles, establishing brand recognition, and scaling operations effectively in a competitive landscape that includes both established players and emerging startups.
Who Are ACCR's Key Customers?
- Medical marijuana growers.
- Medical marijuana dispensaries.
- Pet owners seeking calming products.
Research confidence
Enough evidence to be useful, with gaps worth knowing about.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 73 days ago
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 61 |
| 2026-08-26 | 61 |
| 2026-08-29 | 61 |
| 2026-09-01 | 61 |
| 2026-09-04 | 61 |
| 2026-09-07 | 61 |
| 2026-09-10 | 61 |
What changed?
The score has stayed at 61.
Over the same 18 days the stock moved +2.9%.
Insider Activity
The most recent 12 insider filings for Access-Power & Co., Inc. break down as 2 sales and 10 purchases. On net that is roughly 28.2M shares acquired (about $12003.7B) — insiders putting money in tends to read as conviction.
Quarterly Financial Performance: Access-Power & Co., Inc.
Revenue for Access-Power & Co., Inc. came in at $506K during Q2 FY2026, a 7.3% contraction versus the preceding quarter. The company recorded a net loss of $61K, with diluted EPS of $-0.00. Quarter-over-quarter revenue has been mixed, typical for a unknown company operating in Communication Services. Across the four most recent quarters, ACCR averaged $-0.00 in diluted EPS.
Key Financial Metrics
Return on equity for Access-Power & Co., Inc. stands at -19.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -3.4%, showing how much profit it generates from its asset base. Its free cash flow yield is -25.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.15 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -32.0%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Access-Power & Co., Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -3.06 places it in the distress zone, a signal of elevated financial risk.
Company Profile
Access-Power & Co., Inc. operates in the Software - Application industry within the Technology sector. It is headquartered in Grand Haven, US. The company is led by CEO Pedro Pablo Botta. ACCR has traded publicly since 1997.
ACCR Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Niche market focus on medical marijuana clones.
- Established brand names (Clones By Drones, Clones By Cars).
- Online platform for pet calming products (mycbdpets.com).
- Ongoing: Expansion of the Clones By Drones and Clones by Cars brands through increased distribution and marketing efforts.
Bear Case
- Small scale of operations (1 employee).
- Limited financial resources (market cap of $0.00B).
- Negative profitability (negative P/E and profit margin).
- Potential: Regulatory changes in the cannabis industry that could restrict or prohibit the company's operations.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 FY2026 | $506,186 | -$61,249 | -$0.0001 |
| Q1 FY2026 | $545,861 | -$30,808 | -$0.0001 |
| Q4 FY2025 | $513,985 | -$59,016 | -$0.0001 |
| Q3 FY2025 | $705,848 | -$121,476 | -$0.0003 |
Q2 FY2026 · filed 30 Jun 2026 · SEC EDGAR →
Based on FMP financials and quantitative analysis
ACCR Latest News
-
Array (ARRY) Says its AWM Acquisition Will Be High-Single-Digit Accretive. How Much Depends on Cross-Selling?
Yahoo Finance · Sep 4, 2026
-
Strategy: BTC Accretion Is Working, But I'm Waiting For A Cheaper Entry
All Articles on Seeking Alpha · Aug 29, 2026
-
Stocks That Hit 52-Week Lows On Tuesday
· Mar 24, 2020
-
Stocks That Hit 52-Week Highs On Friday
· Oct 18, 2019
ACCR Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for ACCR.
Price Targets
Wall Street price target analysis for ACCR.
ACCR MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for ACCR; grades run from A+ (80-100) to F (below 30).
Latest News
Array (ARRY) Says its AWM Acquisition Will Be High-Single-Digit Accretive. How Much Depends on Cross-Selling?
Strategy: BTC Accretion Is Working, But I'm Waiting For A Cheaper Entry
Stocks That Hit 52-Week Lows On Tuesday
Stocks That Hit 52-Week Highs On Friday
Leadership: Patrick J. Jensen
Unknown
Patrick J. Jensen serves as the CEO of Access-Power & Co., Inc. As the leader of a small company with only one employee, Jensen's role likely encompasses a wide range of responsibilities, from strategic planning to day-to-day operations.
Track Record: Due to limited information, it is difficult to assess Patrick J. Jensen's track record at Access-Power & Co., Inc. The company's current financial state, characterized by a negative P/E ratio and small market capitalization, suggests significant challenges. However, the gross margin of 59.0% indicates potential for improvement under his leadership.
ACCR OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Access-Power & Co., Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQB or OTCQX. Companies in this tier often have limited trading volume and may not be required to provide regular financial reports, increasing the risk for investors compared to companies listed on major exchanges like NYSE or NASDAQ.
- OTC Tier: OTC Other
- Limited financial disclosure increases information asymmetry and makes it difficult to assess the company's true financial health.
- Low trading volume and liquidity can lead to significant price volatility and difficulty in exiting positions.
- The OTC Other tier has fewer regulatory requirements, increasing the risk of fraud or mismanagement.
- The company's small size and limited resources may hinder its ability to compete effectively in the market.
- The cannabis industry is subject to evolving regulations, which can impact the company's operations and profitability.
- Verify the company's registration and legal standing with the relevant authorities.
- Review any available financial statements and assess the company's financial health.
- Research the company's management team and their experience in the industry.
- Understand the company's business model and competitive landscape.
- Assess the liquidity and trading volume of the stock.
- Be aware of the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- The company has been in operation since 1996, suggesting some level of stability.
- The company has a registered business address in Grand Haven, Michigan.
- The company has a website (mycbdpets.com) for its pet calming products.
Access-Power & Co., Inc. Communication Services Stock: Key Questions Answered
Is ACCR a good stock?
Stock Expert AI does not rate ACCR buy, sell or hold. Access-Power & Co., Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What do analysts say about ACCR stock?
There is currently no available analyst coverage for ACCR stock due to its micro-cap status and listing on the OTC Other tier. Key valuation metrics such as P/E ratio (-3.08) and profit margin (-14.1%) indicate financial challenges. Investors should focus on monitoring the company's revenue growth, gross margin (59.0%), and cash flow to assess its future potential.
What are the key factors to evaluate for ACCR?
Evaluate ACCR on fundamentals, analyst consensus, and risk factors. Investing in Access-Power & Co., Inc. presents a high-risk, high-reward scenario given its presence in the volatile OTC market and the evolving cannabis industry. Not financial advice.
How frequently does ACCR data refresh on this page?
ACCR's price was last updated on Sep 10, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven ACCR's recent stock price performance?
Access-Power & Co., Inc. (ACCR) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Niche market focus on medical marijuana clones. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ACCR overvalued or undervalued right now?
Access-Power & Co., Inc. (ACCR) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of ACCR?
Yes, most major brokerages offer fractional shares of Access-Power & Co., Inc. (ACCR) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track ACCR's earnings and financial reports?
Access-Power & Co., Inc. (ACCR) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for ACCR earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on the company's financials and operations.
- The company's OTC listing and small market capitalization increase investment risk.
- The cannabis industry is subject to evolving regulations.